A phase 1, randomized, double-blind, placebo-controlled, two-period crossover study to investigate the safety of CAL-101 in allergic rhinitis subjects and effects on the response to environmental chamber allergen challenge

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The purpose of this study is to determine the safety and effect of CAL-101 in subjects with allergic rhinitis.
Epistemonikos ID: e674aef1d5f01c0feee1fb75da012931b58d9201
First added on: May 05, 2024